These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15585856)

  • 21. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo.
    Brehm MA; Daniels KA; Ortaldo JR; Welsh RM
    J Immunol; 2005 Jun; 174(11):6663-71. PubMed ID: 15905505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SHIP is required for dendritic cell maturation.
    Antignano F; Ibaraki M; Kim C; Ruschmann J; Zhang A; Helgason CD; Krystal G
    J Immunol; 2010 Mar; 184(6):2805-13. PubMed ID: 20154203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP.
    Collazo MM; Paraiso KH; Park MY; Hazen AL; Kerr WG
    Eur J Immunol; 2012 Jul; 42(7):1785-95. PubMed ID: 22535653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
    Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
    J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells.
    Liu J; Heuer JG; Na S; Galbreath E; Zhang T; Yang DD; Glasebrook A; Song HY
    J Immunol; 2002 Oct; 169(7):3993-8. PubMed ID: 12244201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Separate roles for antigen recognition and lymph node inflammation in CD8+ memory T cell formation.
    Fransen MF; van Stipdonk MJ; Sluijter M; Schoenberger SP; Melief CJ; Offringa R
    J Immunol; 2010 Sep; 185(6):3167-73. PubMed ID: 20696863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen processing of vesicular stomatitis virus in situ. Interdigitating dendritic cells present viral antigens independent of marginal dendritic cells but fail to prime CD4(+) and CD8(+) T cells.
    Ciavarra RP; Greene AR; Horeth DR; Buhrer K; van Rooijen N; Tedeschi B
    Immunology; 2000 Dec; 101(4):512-20. PubMed ID: 11122455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adoptive transfer of allogeneic liver sinusoidal endothelial cells specifically inhibits T-cell responses to cognate stimuli.
    Banshodani M; Onoe T; Shishida M; Tahara H; Hashimoto S; Igarashi Y; Tanaka Y; Ohdan H
    Cell Transplant; 2013; 22(9):1695-708. PubMed ID: 23050792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
    DiPaolo RJ; Unanue ER
    J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses.
    Tarasenko T; Kole HK; Chi AW; Mentink-Kane MM; Wynn TA; Bolland S
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11382-7. PubMed ID: 17585010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
    Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
    J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.